Tumor remission in Yoshida sarcoma-bearing rts by selective targeting of magnetic albumin microspheres containing doxorubicin.
Magnetically responsive albumin microspheres containing doxorubicin and magnetite (Fe3O4) were selectively targeted to Yoshida sarcoma tumors in rats by utilizing an extracorporeal magnet. Tumor cells were inoculated subcutaneously in the tail of rats, and the tumors were allowed to grow to an average size of 9 X 45 mm prior to initiating treatment. Drug-bearing microspheres (0.5 mg of doxorubicin per kg of body weight) were infused proximal to the tumor through the ventral caudal artery while the tumor was exposed to an external magnetic field of 5500 Oe for 30 min. Control animals received free doxorubicin administered either intravenously (5 mg/kg) or infused intraarterially (5 and 0.5 mg/kg), drug-bearing microspheres infused intraarterially (0.5mg/kg), without the external magnet, or placebo microspheres with magnetic localization. Of the 12 animals treated with a single dose in the experimental group, 9 exhibited total remission of the tumor, representing a disappearance of tumors as large as 60 mm in length. Marked tumor regression was observed in the remaining three rats, and no deaths or metastases occurred in the experimental group. In contrast, significant increases in tumor size with widespread metastases occurred in all control groups and most rats died. These experiments indicate that targeting of oncolytic agents to solid neoplasms by magnetic microspheres may be a means of increasing the efficacy and decreasing the toxicity of antitumor agents.
D000418:Albumins / Q000008:administration & dosage; D000818:Animals; D004317:Doxorubicin / Q000008:administration & dosage*; D004338:Drug Combinations; D052203:Ferrosoferric Oxide; D007501:Iron / Q000008:administration & dosage*; D008280:Magnetics; D008863:Microspheres; D009362:Neoplasm Metastasis; D009368:Neoplasm Transplantation; D010087:Oxides; D051381:Rats; D012517:Sarcoma, Yoshida / Q000188:drug therapy*; D014184:Transplantation, Homologous
D000418:Albumins; D004338:Drug Combinations; D010087:Oxides; D004317:Doxorubicin; D007501:Iron; D052203:Ferrosoferric Oxide